6-n-hydroxylaminopurine has been researched along with molybdenum in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dunn, RL; Kozmin, SG; Pavlov, YI; Schaaper, RM | 1 |
| Kozmin, SG; Leroy, P; Pavlov, YI; Schaaper, RM | 1 |
2 other study(ies) available for 6-n-hydroxylaminopurine and molybdenum
| Article | Year |
|---|---|
Hypersensitivity of Escherichia coli Delta(uvrB-bio) mutants to 6-hydroxylaminopurine and other base analogs is due to a defect in molybdenum cofactor biosynthesis.
Topics: Adenine; Bacterial Proteins; Coenzymes; DNA Helicases; DNA Transposable Elements; Drug Resistance, Microbial; Escherichia coli; Escherichia coli Proteins; Gene Deletion; Metalloproteins; Molybdenum; Molybdenum Cofactors; Operon; Point Mutation; Pteridines; Sulfurtransferases | 2000 |
YcbX and yiiM, two novel determinants for resistance of Escherichia coli to N-hydroxylated base analogues.
Topics: Adenine; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Proteins; Hydroxylamine; Molybdenum; Mutagenesis; Mutagenesis, Insertional; Mutation; Open Reading Frames; Oxidoreductases; Protein Structure, Tertiary; Xanthine Dehydrogenase | 2008 |